发明授权
US4016262A Therapeutic compositions and methods employing N(6)-disubstituted
adenosine compounds
失效
使用N(6) - 二取代腺苷化合物的治疗组合物和方法
- 专利标题: Therapeutic compositions and methods employing N(6)-disubstituted adenosine compounds
- 专利标题(中): 使用N(6) - 二取代腺苷化合物的治疗组合物和方法
-
申请号: US582529申请日: 1975-05-30
-
公开(公告)号: US4016262A公开(公告)日: 1977-04-05
- 发明人: Erich Fauland , Wolfgang Kampe , Kurt Stach, deceased , by Werner Plattner, executor , Harald Stork , Karl Dietmann
- 申请人: Erich Fauland , Wolfgang Kampe , Kurt Stach, deceased , by Werner Plattner, executor , Harald Stork , Karl Dietmann
- 申请人地址: DT Mannheim-Waldhof
- 专利权人: Boehringer Mannheim G.m.b.H.
- 当前专利权人: Boehringer Mannheim G.m.b.H.
- 当前专利权人地址: DT Mannheim-Waldhof
- 优先权: DT2338963 19730801
- 主分类号: C07H19/16
- IPC分类号: C07H19/16 ; A61K31/70
摘要:
N(6)-disubstituted adenosine compounds of the formula: ##STR1## wherein R.sub.1 is alkenyl, cycloalkenyl or cycloalkenyl-alkyl; andR.sub.2 is alkenyl, cycloalkenyl, straight or branched-chain alkyl, cycloalkyl, bicycloalkyl, alkyl-cycloalkyl, or alkyl-bicycloalkyl;And the pharmacologically compatible salts thereof; exhibit outstanding anti-lipolytic, anti-hyperlipaemic and anti-hypercholesterolaemic action.